Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 11:38 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » Canadian Stock Picks » Strong Buy: PDP.V // Market Cap $24 M // 6 Marketed Products and Next Big Approval coming in June



Reply
 
Thread Tools Search this Thread
Old 04-15-2015, 12:17 PM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 260
Favorites: Aapl celg onxx
Rep Power: 107
Reputation: 36
Biohero is on a distinguished road
Default PDP.V // Market Cap $24 M // 6 Marketed Products and Next Big Approval coming in June

Pediapharm (PDP.V) has already 6 Products on the Market .

The Asthma Drug is currently the biggest Drug of Pediapharm if approved in 2Q then the Company will reach profitability quickly .Another Drug called Naproxen Suspension licensed from Roche launched last Month so the Revenue will rise significantly in the coming months .This Stock has everything to be the next 10 bagger .GLTA




Market Cap $24 Million
Cash $7.5 Million

Shares Out : 72.1 Million

Insider & Institutions held around 48 Million Shares


Pediapharma Marketed Products
Products - Pediapharm Inc.



The Easyhaler®-budesonide filing is currently under review by Health Canada after clearing the screening process in July 2014. Given the internal Health Canada timelines for such a dossier, the Company remains confident to obtain marketing approval by end of June 2015.

Easyhaler-Budesonide (*) Orion-Finland Asthma Market Size $195 M EST.LAUNCH Q-3 2015







Pediapharm Inc. Announces the Launch of Pediapharm Naproxen Suspension in Canada
Pediapharm expects that the product will be available to patients in March 2015 as it plans to start shipping products to wholesalers and key retailers in late February 2015.
Pediapharm Inc. Announces the Launch of Pediapharm Naproxen Suspension in Canada - Pediapharm Inc.
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 04-17-2015, 04:10 PM   Nav to Top  #2
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 260
Favorites: Aapl celg onxx
Rep Power: 107
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Approval in June could drive this undiscovered to $1 and higher ..Pediapharma is brutally undervalued with a Market Cap of just $25 Million .

PDP.V - SharpCharts Workbench - StockCharts.com


The Easyhaler®-budesonide filing is currently under review by Health Canada after clearing the screening process in July 2014. Given the internal Health Canada timelines for such a dossier, the Company remains confident to obtain marketing approval by end of June 2015.


The Canadian asthma and chronic obstructive pulmonary disease ("COPD") market is estimated to exceed $1 billion annually, of which the single ingredient market is estimated at $500 million annually (IMS Health data December 2012). This market is composed of various classes of molecules. The first class of interest to Pediapharm is the inhaled corticosteroid market which represents over $200 million annually (IMS Health data December 2012). Pediapharm intends to capture market share in this market with the Easyhaler® portfolio of products.


The Easyhaler®portfolio consists of four (4) corticosteroid products, namely, Easyhaler®
budesonide, Easyhaler® salbutamol, Easyhaler® formoterol and Easyhaler® beclomethasone (collectively, the "Easyhaler® Portfolio"). Each single-ingredient Easyhaler® product is designed to treat asthma and COPD.The products comprising the Easyhaler® Portfolio are differentiated from other products on the market by the unique delivery system component of the drug product. As opposed to aerosol-like products, the Easyhaler® Portfolio uses a dry powder to deliver the drugs doses.
Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
3 Kick Ass Trades for June and market Update and Education on channels daytradingradio Traders Lounge 2 11-04-2019 10:44 AM
Strong Buy: IG (Mcap $69M) 3x Products launched// 11x Products awaiting FDA approval Biohero US Stock Picks 2 11-01-2013 09:52 AM
Watch: Paw4mance Pet Products International Inc.(PAWP) Retooling to Grow in Existing Market stockmountie US Penny Stock Picks 1 06-18-2013 08:33 AM
Watch: Market Update for Friday June 14th and Watch List $MA (Best Bet) for tomorrow. and mo daytradingradio US Stock Picks 0 06-14-2013 11:04 AM
Buy: BDSI - FDA approval date June 15th Cuseabuse04 US Stock Picks 141 10-14-2009 08:06 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On